HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Pädiatrische Nephrologie.

Abstract
The aim of this multicentre study was to analyse the long-term outcome of idiopathic membranoproliferative glomerulonephritis (MPGN) according to histological type and to the presence of C3 nephritic factor. Fifty patients aged 2-14 years at the onset of the study were followed over 2-20 years; 26 patients had MPGN type I, 17 had type II and 7 had type III. Treatment was variable. At the last observation, 30 patients had reached terminal and four pre-terminal renal failure. The median survival probability until renal death was 15.3, 8.7 and 15.9 years for disease types I, II and III respectively (difference between MPGN types I + III versus type II: p = 0.013). The presence of an initial nephrotic syndrome was associated with a more rapid progression (p = 0.018). C3 nephritic factor was of no prognostic value. We conclude that the outcome of MPGN mainly depends on the histological type observed.
AuthorsR Schwertz, R de Jong, N Gretz, M Kirschfink, D Anders, K Schärer
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 85 Issue 3 Pg. 308-12 (Mar 1996) ISSN: 0803-5253 [Print] Norway
PMID8695987 (Publication Type: Journal Article)
Chemical References
  • Complement C3 Nephritic Factor
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Complement C3 Nephritic Factor (analysis)
  • Disease Progression
  • Female
  • Glomerulonephritis, Membranoproliferative (complications, pathology, therapy)
  • Humans
  • Kidney (pathology)
  • Kidney Failure, Chronic (etiology)
  • Male
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: